BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND TRAF7, DKFZp586I021, 84231, ENSG00000131653, RNF119, MGC7807, Q6Q0C0, RFWD1
9 results:

  • 1. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
    Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
    Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. traf7-mutated Fibromyxoid Spindle Cell Tumors Are Associated With an Aggressive Clinical Course and Harbor an Undifferentiated Sarcoma Methylation Signature: A Molecular and Clinicopathologic Study of 3 Cases.
    Dermawan JK; Villafania L; Bale T; Singer S; D'Angelo SP; Tap WD; Antonescu CR
    Am J Surg Pathol; 2023 Feb; 47(2):270-277. PubMed ID: 36395468
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular and immunohistochemical characterisation of mesothelioma of the tunica vaginalis
    Anderson WJ; Sholl LM; Fletcher CDM; Schulte S; Wang LJ; Maclean FM; Hirsch MS
    Histopathology; 2022 Jul; 81(1):65-76. PubMed ID: 35460532
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. traf7 mutations and immunohistochemical study of uterine adenomatoid tumor compared with malignant mesothelioma.
    Itami H; Fujii T; Nakai T; Takeda M; Kishi Y; Taniguchi F; Terada C; Okada F; Nitta Y; Matsuoka M; Sasaki S; Sugimoto S; Uchiyama T; Morita K; Kasai T; Kawaguchi R; Ohbayashi C
    Hum Pathol; 2021 May; 111():59-66. PubMed ID: 33667423
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular characterization of diffuse malignant peritoneal mesothelioma.
    Hung YP; Dong F; Torre M; Crum CP; Bueno R; Chirieac LR
    Mod Pathol; 2020 Nov; 33(11):2269-2279. PubMed ID: 32504035
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular characterization of localized pleural mesothelioma.
    Hung YP; Dong F; Dubuc AM; Dal Cin P; Bueno R; Chirieac LR
    Mod Pathol; 2020 Feb; 33(2):271-280. PubMed ID: 31371807
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
    Sneddon S; Dick I; Lee YCG; Musk AWB; Patch AM; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
    Lung Cancer; 2018 May; 119():64-70. PubMed ID: 29656754
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations.
    Bueno R; Stawiski EW; Goldstein LD; Durinck S; De Rienzo A; Modrusan Z; Gnad F; Nguyen TT; Jaiswal BS; Chirieac LR; Sciaranghella D; Dao N; Gustafson CE; Munir KJ; Hackney JA; Chaudhuri A; Gupta R; Guillory J; Toy K; Ha C; Chen YJ; Stinson J; Chaudhuri S; Zhang N; Wu TD; Sugarbaker DJ; de Sauvage FJ; Richards WG; Seshagiri S
    Nat Genet; 2016 Apr; 48(4):407-16. PubMed ID: 26928227
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
    Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
    Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.